Skip to main content
NVDA+0.55%AAPL-0.95%GOOGL-1.49%MSFT-1.06%AMZN-1.96%TSM-1.03%SPCX-1.98%META+0.02%AVGO-1.03%TSLA-0.38%SKHY+0.60%BRK-B+0.15%LLY+0.39%MU+0.78%JPM-0.97%WMT-0.13%AMD+2.29%V-0.54%XOM+1.61%JNJ-1.09%ASMLa-1.36%0700.HK+1.90%MA-0.80%INTC+1.14%ABBV-0.15%1398.HK-2.09%CSCO+0.45%CVX+1.39%BAC+0.08%ORCL-1.05%COST-1.12%KO-0.70%DELL+4.11%CAT-0.85%HSBA.L-1.56%0005.HK-3.21%PG+0.25%UNH-1.43%LRCX-2.43%AP2d-2.35%AMAT-1.34%1816.HK-0.46%3988.HK-2.13%NFLX-2.82%GE-2.42%MS-2.13%0857.HK+0.60%HD-1.46%PM-0.09%0939.HK-2.83%USDJPY+0.97%NZDUSD-0.92%USDTHB+0.74%CHFJPY+0.73%GBPJPY+0.68%CADJPY+0.68%GBPNZD+0.66%NZDCAD-0.62%NZDCHF-0.59%AUDUSD-0.58%EURUSD-0.48%EURJPY+0.46%EURNZD+0.44%GBPTRY+0.41%AUDJPY+0.41%NOKJPY+0.39%PLNJPY+0.37%AUDNZD+0.34%USDCHF+0.33%GBPHKD+0.32%GBPAUD+0.30%USDCAD+0.30%GBPMXN-0.28%NZDMXN-0.28%AUDCAD-0.26%GBPUSD-0.26%SGDJPY+0.26%USDTRY+0.25%AUDCHF-0.23%EURCAD-0.21%USDSGD+0.20%EURGBP-0.20%USDSEK+0.20%USDILS+0.16%EURSGD+0.15%CHFNOK-0.15%EURSEK+0.14%EURCHF-0.13%EURCZK+0.13%GBPSGD+0.12%NZDSGD-0.12%EURAUD+0.11%AUDDKK-0.09%USDPLN+0.09%USDNOK+0.08%USDCNH+0.08%AUDNOK-0.07%AUDSGD+0.06%USDZAR+0.06%NZDJPY+0.06%USDDKK+0.05%GBPCHF+0.05%EURHKD-0.05%USDMXN+0.04%USDCOP-0.04%EURPLN+0.04%GBPCAD+0.04%CHFSEK-0.03%CHFSGD-0.02%CADCHF+0.02%GBPZAR-0.02%USDHKD+0.02%EURNOK+0.02%EURDKK-0.01%EURZAR+0.01%EURCNH0.00%USOIL+2.67%UKOIL+1.94%W1+1.65%XNGUSD+1.39%COFFEE-0.97%C1+0.80%S1+0.79%SUGAR-0.72%COCOA-0.55%XAUUSD-0.51%GAUUSD-0.51%HG1+0.27%BTCUSD-2.84%ETHUSD-4.23%USDTUSD-0.04%XRPUSD-2.79%SOLUSD-3.58%TRXUSDT-0.41%ZECUSDT-4.17%DOGEUSD-2.84%XMRUSDT-0.09%LINKUSD-2.96%XLMUSD-0.71%BCHUSDT-2.19%UNIUSD-3.98%LTCUSD-2.96%HBARUSDT-0.71%TONUSD+26.79%SUIUSD-3.38%TAOUSDT-3.99%AAVEUSD-3.05%DOTUSDT-2.91%ICPUSDT-7.47%ONDOUSDT-4.25%WLDUSDT-2.35%ARBUSDT+2.72%ATOMUSDT-2.10%JUPUSDT-5.14%INJUSDT-9.70%STXUSDT-3.87%FETUSDT-4.78%PYTHUSDT-5.16%TIAUSDT-6.71%SEIUSDT-3.59%IMXUSDT-1.81%OPUSDT-3.66%GRTUSDT-4.37%WIFUSDT-5.33%POLUSDT-0.50%IOTAUSDT-6.20%AXSUSDT-3.68%FARTCOINUSDT-2.43%EOSUSDT-4.69%DYDXUSDT-6.82%ORDIUSDT-2.55%GALAUSDT-2.06%NOTUSDT-2.37%RONINUSDT-7.55%NVDA+0.55%AAPL-0.95%GOOGL-1.49%MSFT-1.06%AMZN-1.96%TSM-1.03%SPCX-1.98%META+0.02%AVGO-1.03%TSLA-0.38%SKHY+0.60%BRK-B+0.15%LLY+0.39%MU+0.78%JPM-0.97%WMT-0.13%AMD+2.29%V-0.54%XOM+1.61%JNJ-1.09%ASMLa-1.36%0700.HK+1.90%MA-0.80%INTC+1.14%ABBV-0.15%1398.HK-2.09%CSCO+0.45%CVX+1.39%BAC+0.08%ORCL-1.05%COST-1.12%KO-0.70%DELL+4.11%CAT-0.85%HSBA.L-1.56%0005.HK-3.21%PG+0.25%UNH-1.43%LRCX-2.43%AP2d-2.35%AMAT-1.34%1816.HK-0.46%3988.HK-2.13%NFLX-2.82%GE-2.42%MS-2.13%0857.HK+0.60%HD-1.46%PM-0.09%0939.HK-2.83%USDJPY+0.97%NZDUSD-0.92%USDTHB+0.74%CHFJPY+0.73%GBPJPY+0.68%CADJPY+0.68%GBPNZD+0.66%NZDCAD-0.62%NZDCHF-0.59%AUDUSD-0.58%EURUSD-0.48%EURJPY+0.46%EURNZD+0.44%GBPTRY+0.41%AUDJPY+0.41%NOKJPY+0.39%PLNJPY+0.37%AUDNZD+0.34%USDCHF+0.33%GBPHKD+0.32%GBPAUD+0.30%USDCAD+0.30%GBPMXN-0.28%NZDMXN-0.28%AUDCAD-0.26%GBPUSD-0.26%SGDJPY+0.26%USDTRY+0.25%AUDCHF-0.23%EURCAD-0.21%USDSGD+0.20%EURGBP-0.20%USDSEK+0.20%USDILS+0.16%EURSGD+0.15%CHFNOK-0.15%EURSEK+0.14%EURCHF-0.13%EURCZK+0.13%GBPSGD+0.12%NZDSGD-0.12%EURAUD+0.11%AUDDKK-0.09%USDPLN+0.09%USDNOK+0.08%USDCNH+0.08%AUDNOK-0.07%AUDSGD+0.06%USDZAR+0.06%NZDJPY+0.06%USDDKK+0.05%GBPCHF+0.05%EURHKD-0.05%USDMXN+0.04%USDCOP-0.04%EURPLN+0.04%GBPCAD+0.04%CHFSEK-0.03%CHFSGD-0.02%CADCHF+0.02%GBPZAR-0.02%USDHKD+0.02%EURNOK+0.02%EURDKK-0.01%EURZAR+0.01%EURCNH0.00%USOIL+2.67%UKOIL+1.94%W1+1.65%XNGUSD+1.39%COFFEE-0.97%C1+0.80%S1+0.79%SUGAR-0.72%COCOA-0.55%XAUUSD-0.51%GAUUSD-0.51%HG1+0.27%BTCUSD-2.84%ETHUSD-4.23%USDTUSD-0.04%XRPUSD-2.79%SOLUSD-3.58%TRXUSDT-0.41%ZECUSDT-4.17%DOGEUSD-2.84%XMRUSDT-0.09%LINKUSD-2.96%XLMUSD-0.71%BCHUSDT-2.19%UNIUSD-3.98%LTCUSD-2.96%HBARUSDT-0.71%TONUSD+26.79%SUIUSD-3.38%TAOUSDT-3.99%AAVEUSD-3.05%DOTUSDT-2.91%ICPUSDT-7.47%ONDOUSDT-4.25%WLDUSDT-2.35%ARBUSDT+2.72%ATOMUSDT-2.10%JUPUSDT-5.14%INJUSDT-9.70%STXUSDT-3.87%FETUSDT-4.78%PYTHUSDT-5.16%TIAUSDT-6.71%SEIUSDT-3.59%IMXUSDT-1.81%OPUSDT-3.66%GRTUSDT-4.37%WIFUSDT-5.33%POLUSDT-0.50%IOTAUSDT-6.20%AXSUSDT-3.68%FARTCOINUSDT-2.43%EOSUSDT-4.69%DYDXUSDT-6.82%ORDIUSDT-2.55%GALAUSDT-2.06%NOTUSDT-2.37%RONINUSDT-7.55%
MB

MBX Biosciences, Inc. Common Stock (MBX)

NASDAQ • Healthcare

$59.49
+$0.46 (+0.8%)
Market open

Last close at September 14, 2026 at 20:00 UTC

Open$59.35
Previous Close$59.49
Day Range$58.87 - $60.22
Avg. Volume (3M)379.2K
Market Cap$2.7B
52 Week Range
$9.64$72.64
Next EarningsIn 51 daysNov 5, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$104.2M
EPS (TTM)
-$2.4
ROA (TTM)
-23.93%
Current Ratio
18.08

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+23.4%Q1 2026-$0.49
+17.7%Q2 2026-$0.51
-23.3%Q3 2026-$0.78
Next

Nov 5

in 51 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -23.3%

MBX Biosciences missed on EPS in the second fiscal quarter of 2026, with preliminary results reported Aug. 6 showing EPS of -$0.78 versus the -$0.63 estimate, about -23%, and down 34.5% from -$0.58 a year earlier. Net income came in at roughly negative $37.1 million, down 91.1% from negative $19.4 million a year ago, while operating income was about negative $40.9 million and operating cash flow was negative about $42.8 million. Consensus for the next period calls for EPS of -$0.78.

View full earnings history

About MBX Biosciences, Inc. Common Stock

MBX Biosciences, Inc. is a clinical-stage biotechnology company listed on the NASDAQ as MBX that develops precise peptide-based therapies for endocrine and metabolic conditions. Its work centers on peptide drug candidates aimed at hormone and metabolic disorders rather than marketed products, placing the company in the biopharmaceutical development phase.

Name
MBX Biosciences, Inc. Common Stock
CEO
Steve Hoerter
Website
mbxbio.com
Industry
Healthcare
Year Founded
2018
Employees
63

Today's Snapshot

AI-generated

MBX closed 0.8% higher at 59.49.

Trading Volume

Below 10d avg (352.0K)

323.6K

vs S&P 500 Today

Outperforming Market

+1.28%

Updated: September 15, 2026 at 12:26 UTC

Technical Indicators

3 Buy1 Neutral4 Sell
MBX exhibits short-term weakness within a longer-term uptrend, trading near $59.49 while falling beneath several short- and medium-term moving averages even though longer-term averages remain below price. Momentum and trend indicators are negative—MACD is notably below zero and CCI is deeply negative—while volatility is elevated (ATR about 5.2%), and OBV is indicating net selling pressure. ADX suggests a developing directional move rather than a strong trend. Technical takeaway: near-term bias is bearish as weakening momentum and distribution pressure outweigh the longer-term support shown by the 100/200-day averages.
All signals
  • EMA (5 indicators)$43.51 - $62.77
    Sell
  • RSI (14)39.78
    Neutral
  • Stochastic %K (14, 3, 3)11.69
    Buy
  • MACD Level (12, 26)-0.92
    Sell

Peers & Related Assets

ERASErasca, Inc.
$16.16+1.8%
IOVAIovance Biotherapeutics, Inc.
$9.26+7.7%
AVBPArriVent BioPharma, Inc.
$28.57-1.5%
MGTXMeiraGTx Holdings plc
$12.88+0.7%
REPLReplimune Group, Inc.
$13.11+1.5%
VSTMVerastem, Inc.
$7.51+2.6%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.